e-learning
resources
Glasgow 2004
Tuesday 07.09.2004
Lung fibrosis sarcoidosis alveolar microlithiasis and proteinosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Interstitial lung diseases, mortality and associated risk factors
M. C. De Salvo, J. A. Gonzalez, D. R. Rey, A. M. Miranda (Buenos Aires, Argentina)
Source:
Annual Congress 2004 - Lung fibrosis sarcoidosis alveolar microlithiasis and proteinosis
Session:
Lung fibrosis sarcoidosis alveolar microlithiasis and proteinosis
Session type:
Poster Discussion
Number:
4074
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. C. De Salvo, J. A. Gonzalez, D. R. Rey, A. M. Miranda (Buenos Aires, Argentina). Interstitial lung diseases, mortality and associated risk factors. Eur Respir J 2004; 24: Suppl. 48, 4074
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Lane-hamilton syndrome and CCF: a fatal association
A 12-year-old male child with fever, productive cough and sudden onset paralysis
Related content which might interest you:
Risk factors associated with the development of interstitial lung abnormalities
Source: Eur Respir J, 58 (2) 2003005; 10.1183/13993003.03005-2020
Year: 2021
Predictors of mortality and risk prediction among patients with scleroderma related interstitial lung disease
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015
Risk factors for early mortality in lung cancer
Source: Annual Congress 2012 - Epidemiology and care research of lung cancer
Year: 2012
The analysis of prognostic factors in patients with interstitial lung diseases
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Incidence and risk factors for structural lung disease following SARS-CoV-2 infection
Source: Virtual Congress 2021 – COVID - 19 risk predictions
Year: 2021
Associations between comorbidities and survival in patients with interstitial lung diseases
Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases
Year: 2021
Interstitial lung abnormalities in smokers are associated with increased mortality
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017
Prevalence of and risk factors for pulmonary complications after lung cancer surgery in elderly patients with preserved lung function
Source: International Congress 2018 – Lung cancer: modern therapies and beyond
Year: 2018
Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome
Source: Eur Respir J 2011; 37: 356
Year: 2011
Interstital lung disease rates and risk factors in a UK lung cancer screening trial
Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries
Year: 2018
Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD).
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
Intolarence of pirfenidone and its associated factors in the real world
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016
Interstitial lung diseases associated with lung cancer
Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer
Year: 2016
Risk factors for pulmonary hypertension and associations with lung function in connective tissue diseases
Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Year: 2010
Risk factors for lung cancer worldwide
Source: Eur Respir J 2016; 48: 889-902
Year: 2016
Combination of risk factors of bronchopulmonary and cardiovascular diseases in people of young age
Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases
Year: 2009
Effect of autoimmune diseases on risk and survival in histology-specific lung cancer
Source: Eur Respir J 2012; 40: 1489-1495
Year: 2012
The associations of interstitial lung abnormalities with cancer diagnoses and mortality
Source: Eur Respir J, 56 (6) 1902154; 10.1183/13993003.02154-2019
Year: 2020
Incidence, risk factors and outcomes of nonresolving pneumonia
Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept